- Home
- MTZ vs MEDP Comparison
MTZ vs MEDP Comparison
Compare MTZ & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTZ
- MEDP
- Stock Information
- Founded
- MTZ 1929
- MEDP 1992
- Country
- MTZ United States
- MEDP United States
- Employees
- MTZ N/A
- MEDP N/A
- Industry
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MTZ Industrials
- MEDP Health Care
- Exchange
- MTZ Nasdaq
- MEDP Nasdaq
- Market Cap
- MTZ 13.1B
- MEDP 8.5B
- IPO Year
- MTZ N/A
- MEDP 2016
- Fundamental
- Price
- MTZ $171.89
- MEDP $321.50
- Analyst Decision
- MTZ Strong Buy
- MEDP Hold
- Analyst Count
- MTZ 19
- MEDP 11
- Target Price
- MTZ $167.11
- MEDP $338.90
- AVG Volume (30 Days)
- MTZ 844.5K
- MEDP 420.8K
- Earning Date
- MTZ 07-31-2025
- MEDP 07-21-2025
- Dividend Yield
- MTZ N/A
- MEDP N/A
- EPS Growth
- MTZ N/A
- MEDP 33.36
- EPS
- MTZ 2.70
- MEDP 13.09
- Revenue
- MTZ $12,464,333,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- MTZ $12.37
- MEDP $5.64
- Revenue Next Year
- MTZ $8.88
- MEDP $3.32
- P/E Ratio
- MTZ $63.56
- MEDP $24.56
- Revenue Growth
- MTZ 3.03
- MEDP 9.87
- 52 Week Low
- MTZ $89.96
- MEDP $250.05
- 52 Week High
- MTZ $173.24
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- MTZ 67.38
- MEDP 65.60
- Support Level
- MTZ $164.13
- MEDP $305.69
- Resistance Level
- MTZ $172.71
- MEDP $314.58
- Average True Range (ATR)
- MTZ 4.10
- MEDP 8.28
- MACD
- MTZ -0.26
- MEDP 2.39
- Stochastic Oscillator
- MTZ 89.98
- MEDP 98.59
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.